1. Home >
  2. M&A >
  3. Venture >
  4. United States >
  5. California >
  6. Alta Partners Invests In Pathwork Diagnostics

Venture • Life Science

Alta Partners Invests In Pathwork Diagnostics

On October 6, 2010, venture capital firm Alta Partners invested in life science company Pathwork Diagnostics for 30M USD

Investment Context
  • This is Alta Partners’ 42nd transaction in the Life Science sector.
  • This is Alta Partners’ 2nd largest (disclosed) transaction.
  • This is Alta Partners’ 42nd transaction in the United States.
  • This is Alta Partners’ 28th transaction in California.
Investment Fate
  • Pathwork Diagnostics was sold to a publicly-traded strategic buyer in 2013.

Explore All 557 Venture Life Science Deals - Search the Database Free


Investment Summary
Date October 6, 2010
Target Pathwork Diagnostics
Sector Life Science
Investor(s) Alta Partners
Deal Type Venture
Deal Value 30M USD

Target Company

Pathwork Diagnostics

Redwood City, California, United States
Pathwork Diagnostics Inc. is a privately held company that develops and delivers innovative molecular diagnostics for oncology. Pathwork's Tissue of Origin Test identifies the source of cancers that are difficult to classify and increases oncologists’ confidence in their treatment approaches. It is the only FDA-approved molecular diagnostic test for tissue of origin.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

Alta Partners

Jackson, Wyoming, United States

Investor Investor Investor Investor

Category Venture Capital Firm
Founded 1996
PE ASSETS 2.6B USD
Size Large
Type Sector Focused
DESCRIPTION

Alta Partners is a venture capital firm that targets investments in early and later stage life science companies, including biopharmaceuticals, medical technology, and information technology businesses. Alta was formed as an early stage investor but has since expanded its investment range to provide later stage growth capital to private and young public companies. Alta was established in 1996 and is headquartered in San Francisco, California.

Deal Context for Investor #
Overall 50 of 59
Sector: Life Science 42 of 50
Type: Venture 41 of 48
State: California 28 of 31
Country: United States 42 of 50
Year: 2010 4 of 4
Size (of disclosed) 2 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-10-06 FoldRx Pharmaceuticals

Cambridge, Massachusetts, United States

FoldRx Pharmaceuticals is a development and discovery company focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding and aggregation (amyloidosis). The Company's lead product, FX-4006, has begun a Phase II/III study in familial amyloid polyneuropathy. FoldRx Pharmaceuticals was founded in 2003 and is based in Cambridge, Massachusetts.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-10-22 Aegerion Pharmaceuticals

Cambridge, Massachusetts, United States

Aegerion Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of pharmaceutical products to treat cardiovascular and metabolic diseases. Aegerion Pharmaceuticals, Inc. was formed in 2005 and is headquartered in Cambridge, Massachusetts.

Sell -

Explore Related M&A Activity

Life Science M&A - Venture M&A Deals - California M&A - United States M&A - 2010 M&A

Mergr

Solution for

Product

Company

Legal